Skip to content

ARCH Venture Fund IX Overage, L.P.

Reporting owner on Forms 3, 4 and 5, CIK 1666307.

ARCH Venture Fund IX Overage, L.P. reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-06.

Issuers

IssuerRoles in the latest filingFilingsLast filed
LYEL · Lyell Immunopharma, Inc.CIK 180695210% owner12026-11-05

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
LYEL · Lyell Immunopharma, Inc.Common Stock2026-11-04P bought+2,321,262$10.773,747,790Form 4
LYEL · Lyell Immunopharma, Inc.Common Stock, holding 910,317Form 4
LYEL · Lyell Immunopharma, Inc.Common Stock, holding 910,317Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0001012975-26-001020 VIR2026-11-06
Form 4 0001012975-26-001014 Lyell Immunopharma, Inc.2026-11-05